(THC) Tenet Healthcare - Ratings and Ratios

Tenet Healthcare Corporation (NYSE:THC) is a leading U.S.-based healthcare services provider, founded in 1967 and headquartered in Dallas, Texas. The company operates through two key segments: Hospital Operations and Services, and Ambulatory Care. Its general acute care hospitals provide a wide range of medical services, including emergency care, surgical procedures, radiology, respiratory therapy, clinical laboratories, and pharmacies. Specialized services include intensive care, coronary care, cardiovascular and neurosciences programs, as well as advanced surgical offerings such as cardiothoracic and complex spinal surgeries. The company also offers pediatric quaternary care, including heart, liver, and kidney transplants, and advanced vascular procedures. Additionally, Tenet provides orthopedic, gastroenterology, pain management, and urology services across its network of hospitals, ambulatory surgery centers, urgent care centers, imaging centers, and micro-hospitals.

Tenets operational footprint includes over 60 hospitals and more than 500 ambulatory facilities, positioning it as a diversified healthcare provider with a strong focus on both inpatient and outpatient care. The company has embraced advanced medical technologies, including surgical robotics and telemedicine, to enhance patient access and improve clinical outcomes. Its ambulatory care segment emphasizes convenience and cost efficiency, offering services such as physical therapy, imaging, and urgent care through its network of outpatient facilities.

From a financial perspective, Tenet Healthcare Corporation has a market capitalization of $12.47 billion USD, with a trailing P/E ratio of 4.01 and a forward P/E of 9.88. The companys price-to-book ratio stands at 2.73, and its price-to-sales ratio is 0.60. Return on equity is notably high at 76.72%, indicating strong profitability relative to shareholder equity. Technically, the stock has shown recent volatility, with an ATR of 6.33 and a 20-day average volume of 1,365,965 shares. Its current price of $114.68 is below key moving averages, with the 20-day SMA at $126.22, the 50-day SMA at $127.81, and the 200-day SMA at $142.76.